Clinical Trial Update: Dendritic Cell Vaccination During Lymphoid Reconstruction [Phase 1]

View source ↗

Summary

Phase 1 trial of dendritic cell vaccination during lymphoid reconstruction for uveal melanoma and cutaneous melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Uveal Melanoma

Drugs mentioned

• Dendritic Cell Vaccine (investigational)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 1 | Status: COMPLETED